Patents by Inventor Phanesh B. Koneru

Phanesh B. Koneru has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12161617
    Abstract: Stable methocarbamol ready to use compositions for parenteral administration including parenteral infusion are provided. In certain embodiments, the compositions are sterile, isotonic, and particulate-matter-free. Further, the compositions reduce or avoid allergic reactions to latex, reduce or avoid extravasation, and permit administration of methocarbamol to subjects having renal pathology. Methods of manufacture and methods of administration are also provided.
    Type: Grant
    Filed: November 28, 2022
    Date of Patent: December 10, 2024
    Assignee: EXELA STERILE MEDICINES LLC
    Inventors: Phanesh B. Koneru, John Maloney
  • Publication number: 20240181064
    Abstract: Gancyclovir formulations that are ready-to-use, substantially particulate free, and stable upon storage are disclosed. Methods of manufacture and administration of such compositions are also provided.
    Type: Application
    Filed: August 14, 2023
    Publication date: June 6, 2024
    Applicant: Exela Pharma Sciences, LLC
    Inventors: Sreerama Murthy Mallipeddi, Jonathan E. Sterling, Phanesh B. Koneru
  • Patent number: 11723978
    Abstract: Gancyclovir formulations that are ready-to-use, substantially particulate free, and stable upon storage are disclosed. Methods of manufacture and administration of such compositions are also provided.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: August 15, 2023
    Assignee: Exela Pharma Sciences, LLC
    Inventors: Sreerama Murthy Mallipeddi, Jonathan E. Sterling, Phanesh B. Koneru
  • Publication number: 20230107569
    Abstract: Stable methocarbamol ready to use compositions for parenteral administration including parenteral infusion are provided. In certain embodiments, said compositions are sterile, isotonic, and particulate-matter-free. Further, said compositions reduce or avoid allergic reactions to latex, reduce or avoid extravasation, and permit administration of methocarbamol to subjects having renal pathology. Methods of manufacture and methods of administration are also provided.
    Type: Application
    Filed: November 28, 2022
    Publication date: April 6, 2023
    Inventors: Phanesh B. Koneru, John Maloney
  • Patent number: 11510893
    Abstract: Stable methocarbamol ready to use compositions for parenteral administration including parenteral infusion are provided. In certain embodiments, the compositions are sterile, isotonic, and particulate-matter-free. Further, the compositions reduce or avoid allergic reactions to latex, reduce or avoid extravasation, and permit administration of methocarbamol to subjects having renal pathology. Methods of manufacture and methods of administration are also provided.
    Type: Grant
    Filed: January 19, 2022
    Date of Patent: November 29, 2022
    Assignee: Exela Sterile Medicines LLC
    Inventors: Phanesh B. Koneru, John Maloney
  • Patent number: 11266621
    Abstract: Stable methocarbamol ready to use compositions for parenteral administration including parenteral infusion are provided. In certain embodiments, the compositions are sterile, isotonic, and particulate-matter-free. Further, the compositions reduce or avoid allergic reactions to latex, reduce or avoid extravasation, and permit administration of methocarbamol to subjects having renal pathology. Methods of manufacture and methods of administration are also provided.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: March 8, 2022
    Assignee: Exela Sterile Medicines LLC
    Inventors: Phanesh B. Koneru, John Maloney
  • Publication number: 20200316075
    Abstract: Gancyclovir formulations that are ready-to-use, substantially particulate free, and stable upon storage are disclosed. Methods of manufacture and administration of such compositions are also provided.
    Type: Application
    Filed: March 10, 2020
    Publication date: October 8, 2020
    Applicant: Exela Pharma Sciences, LLC
    Inventors: Sreerama Murthy Mallipeddi, Jonathan E. Sterling, Phanesh B. Koneru
  • Patent number: 9486530
    Abstract: Gancyclovir formulations that are ready-to-use, substantially particulate free, and stable upon storage are disclosed. Methods of manufacture and administration of such compositions are also provided.
    Type: Grant
    Filed: September 2, 2014
    Date of Patent: November 8, 2016
    Assignee: Exela Pharma Sciences, LLC
    Inventors: Sreerama Murthy Mallipeddi, Jonathan E. Sterling, Phanesh B. Koneru